Press release
Leading Companies Fueling Growth and Innovation in the Cancer Vaccines Market
Cancer Vaccines Market
Projected Market Size and Growth Trajectory of the Cancer Vaccines Market
The cancer vaccines market is forecasted to experience rapid growth, reaching a valuation of $18.2 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 14.3% during the forecast period. The surge can be credited to ongoing innovations in vaccine platforms and delivery methods, the increasing use of personalized cancer vaccines, a swelling pipeline of therapeutic vaccines under clinical development, greater government funding dedicated to cancer research, and the rising demand for combination therapies in oncology. Notable trends driving this momentum include a focus on therapeutic vaccines, personalized immunotherapy approaches, the intensification of clinical trials for novel vaccine technologies, growing preventive vaccination programs aimed at cancer avoidance, and strengthened partnerships between pharmaceutical companies and research institutions.
Download a free sample of the cancer vaccines market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Players Leading the Cancer Vaccines Market
The competitive landscape of the cancer vaccines market features a variety of prominent companies actively involved in developing and commercializing these therapies. Key players include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen, Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., and Ziopharm Oncology Inc.
Collaborative Advances in Personalized Cancer Vaccine Production
In August 2024, NEC Bio Therapeutics, a US-based biotech firm focused on personalized immunotherapies, announced a strategic collaboration with AGC Biologics to scale the manufacturing of individualized cancer vaccines. This partnership aims to accelerate NEC's neoantigen vaccine programs by utilizing AGC Biologics' global biologics manufacturing expertise. The joint effort is designed to enable efficient, high-quality production of personalized cancer treatments, improving clinical development timelines and patient access. AGC Biologics is recognized as a leading US contract development and manufacturing organization (CDMO) that delivers comprehensive solutions for biologics manufacturing.
View the full cancer vaccines market report:
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Increasing Focus on Quadrivalent Vaccines and Preventive Cancer Immunization
Industry players are placing heightened emphasis on quadrivalent vaccines to broaden protection against multiple virus strains and enhance market revenue. Quadrivalent vaccines target four different strains or types of viruses or bacteria, which increases their preventive effectiveness. For example, in January 2023, the Serum Institute of India introduced CERVAVAC, the country's first indigenous cervical cancer vaccine. This vaccine targets HPV types 16, 18, 6, and 11, which collectively cause around 70% of cervical cancer cases. It is administered through injections-two doses for individuals aged 9 to 14 and three doses for those aged 15 to 26-enhancing protection in these vulnerable age groups.
Segmentation Overview of the Global Cancer Vaccines Market
The cancer vaccines market is categorized into several key segments for detailed analysis:
1) By Type: Preventive Cancer Vaccines and Therapeutic Cancer Vaccines
2) By Technology: Dendritic Cell (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, and Viral Vector & DNA Cancer Vaccines
3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, and Other Cancer Types
4) By End-User: Cancer Treatment Centers and Research Institutes
Further subsegments include:
- Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines
- Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), and other therapeutic vaccines
These classifications provide a comprehensive understanding of the market's diverse product offerings and application areas, helping stakeholders navigate the evolving landscape.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Fueling Growth and Innovation in the Cancer Vaccines Market here
News-ID: 4496652 • Views: …
More Releases from The Business Research Company
Emerging Sub-Segments Transforming the Anti-Aging Drugs Market Landscape
The market for anti-aging drugs is attracting significant attention as advancements in technology and healthcare continue to evolve. Increasing consumer interest in personalized and preventive care is shaping this dynamic sector, which is poised for substantial expansion over the coming years. Let's explore the current market valuation, key players, trends, and segment breakdowns that define the anti-aging drugs industry.
Projected Market Size and Growth Trajectory of the Anti-Aging Drugs Market …
Outlook on the Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Ma …
The chimeric antigen receptor-natural killer (CAR-NK) cell therapy market is poised for substantial expansion over the coming years as advancements in cellular therapies continue to accelerate. Innovations in genetic engineering and clinical applications are driving increasing interest and investment, setting the stage for significant growth by 2030. Let's explore the market size projections, key industry players, emerging trends, and segmentation details that define this evolving sector.
Projected Market Size and Growth…
Top Companies and the Competitive Environment in the Cancer Supportive Care Drug …
The cancer supportive care drugs market is poised for steady expansion as the global healthcare landscape evolves. With advances in oncology and a growing focus on improving patient quality of life, this sector is expected to witness significant developments through 2030. Let's explore the market's size projections, key drivers, leading companies, emerging trends, and segmentation to understand the opportunities ahead.
Projected Growth and Market Size of Cancer Supportive Care Drugs by…
In-Depth Examination of Segments, Industry Trends, and Key Players in the Chemot …
The chemotherapy market is set to experience substantial growth over the coming years, driven by advancements in personalized treatments and increasing demand for innovative therapy options. As cancer care evolves with new technologies and approaches, the chemotherapy sector is positioned to expand rapidly, with several factors shaping its future outlook.
Anticipated Growth Trajectory of the Chemotherapy Market by 2030
The chemotherapy market is projected to reach a valuation of $68.44…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
